Naloxone hydrochloride, synthesized in 1960, is a derivative of hydroxy (di)morphinone. Naloxone is an opioid receptor antagonist primarily used to counteract opioid overdose. It has respiratory stimulant and awakening effects, making it an effective antidote for opioid overdose and a diagnostic tool for opioid and heroin dependence. Building on the research of endogenous opioid-like substances\' physiological effects, clinical practitioners have found success in using naloxone not only to reverse opioid-induced respiratory depression but also in the treatment of non-anesthetic drug overdose (such as alcohol and benzodiazepines), shock, cerebral infarction, neonatal asphyxia syndrome, and other stress-related disorders. This has garnered significant interest among medical professionals both domestically and internationally. In recent years, clinicians have also utilized naloxone in the treatment of acute alcohol and sedative poisoning, hepatic encephalopathy, cerebral infarction, post-asphyxial ischemic encephalopathy in neonates, severe heatstroke, acute and chronic respiratory failure, as well as various critical shock conditions, all with positive outcomes.
Packaging： 1000 vials per case
Specifications： 0.8mg 2mg 4.0mg
Shelf Life： 30 months
Approval Number： 国药准字H20080551 国药准字H20080629 国药准字H20080552
Indications： This product is an opioid receptor antagonist. 1. Used to reverse respiratory depression caused by opioids after opioid-based anesthesia, promoting patient awakening. 2. Used to completely or partially reverse respiratory depression caused by opioid overdose. 3. Used in the rescue treatment of acute ethanol poisoning. 4. Used for the diagnosis of acute opioid overdose. 5. First-line medication for the treatment of acute ethanol and opioid substance poisoning. 6. Significant efficacy in restoring autonomous respiration in various acute poisoning cases. 7. A fast-acting, potent, and safe specific μ-receptor antagonist. 8. Rapid relief of all central nervous system-related dizziness and coma symptoms. 9. Covered by medical insurance and agricultural cooperative medical care programs (in China).
Detail
1. Used to reverse respiratory depression caused by opioids after opioid-based anesthesia, promoting patient awakening.
2. Used to completely or partially reverse respiratory depression caused by opioid overdose.
3. Used in the rescue treatment of acute ethanol poisoning.
4. Used for the diagnosis of acute opioid overdose.
5. First-line medication for the treatment of acute ethanol and opioid substance poisoning.
6. Significant efficacy in restoring autonomous respiration in various acute poisoning cases.
7. A fast-acting, potent, and safe specific μ-receptor antagonist.
8. Rapid relief of all central nervous system-related dizziness and coma symptoms.
9. Covered by medical insurance and agricultural cooperative medical care programs (in China).
